Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.

about

Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.

Item

http://www.wikidata.org/entity/Q49819979

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Artificial Differences in Clos ...... ted with Disparity in Testing.

@en

Artificial Differences in Clos ...... ted with Disparity in Testing.

@nl

type

Item

label

Artificial Differences in Clos ...... ted with Disparity in Testing.

@en

Artificial Differences in Clos ...... ted with Disparity in Testing.

@nl

prefLabel

Artificial Differences in Clos ...... ted with Disparity in Testing.

@en

Artificial Differences in Clos ...... ted with Disparity in Testing.

@nl

P1476

Artificial Differences in Clos ...... ted with Disparity in Testing.

@en

P2093

Amber Moyer

http://www.w3.org/2001/XMLSchema#string

Annemarie Flood

http://www.w3.org/2001/XMLSchema#string

Anoshe Aslam

http://www.w3.org/2001/XMLSchema#string

Belinda Ostrowsky

http://www.w3.org/2001/XMLSchema#string

Candace Hsieh

http://www.w3.org/2001/XMLSchema#string

David Calfee

http://www.w3.org/2001/XMLSchema#string

Deborah A Fry

http://www.w3.org/2001/XMLSchema#string

Deborah Korenstein

http://www.w3.org/2001/XMLSchema#string

Denise Mitchell

http://www.w3.org/2001/XMLSchema#string

Donald Chen

http://www.w3.org/2001/XMLSchema#string

P2860

An epidemic, toxin gene-variant strain of Clostridium difficile.

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.

Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.

Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.

Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Toxin Immunoassays and Clostridium difficile Infection-Reply.

Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.

Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?

P304

584-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID2403.170961

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29460760

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

5823336

http://www.w3.org/2001/XMLSchema#string